Literature DB >> 29953269

Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.

Pierfrancesco Franco1, Francesca Arcadipane1, Riccardo Ragona1, Adriana Lesca2, Elena Gallio3, Massimiliano Mistrangelo4, Elisabetta Trino1, Paola Cassoni5, Vincenzo Arena6, Massimo Baccega2, Patrizia Racca7, Riccardo Faletti8, Nadia Rondi9, Mario Morino4, Umberto Ricardi1.   

Abstract

PURPOSE: To investigate whether irradiated volume of pelvic active bone marrow (ACTBM) may predict decreased blood cells nadirs in anal cancer patients undergoing concurrent chemo-radiation.
METHODS: Forty-four patients were analyzed and pelvic active bone marrow (ACTBM) was characterized employing 18FDG-PET. Dosimetric parameters on dose-volume histograms were correlated to nadirs with generalized linear modeling.
RESULTS: ACTBM mean dose was significantly correlated to white blood cell (β = -1.338; 95%CI: -2.455/-0.221; p = 0.020), absolute neutrophil count (β = -1.651; 95%CI: -3.284/-0.183; p = 0.048), and platelets (β = -0.031; 95%CI: -0.057/-0.004; p = 0.024) nadirs. Other dosimetric parameters were found to be correlated (ACTBM-V10,-V20,-V30and-V40).
CONCLUSIONS: 18FDG-PET is able to define active bone marrow and may predict for decreased blood cells count nadirs.

Entities:  

Keywords:  Anal cancer; Bone marrow; Concomitant radiochemotherapy; Hematologic toxicity; IMRT; PET; Radiotherapy

Mesh:

Substances:

Year:  2018        PMID: 29953269     DOI: 10.1080/07357907.2018.1479413

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer.

Authors:  Łukasz Kuncman; Konrad Stawiski; Michał Masłowski; Jakub Kucharz; Jacek Fijuth
Journal:  Strahlenther Onkol       Date:  2020-07-03       Impact factor: 3.621

2.  Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer.

Authors:  Martin P Nilsson; Anders Johnsson; Jonas Scherman
Journal:  Radiat Oncol       Date:  2021-08-16       Impact factor: 3.481

3.  Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.

Authors:  Pavel Vítek; Jiří Kubeš; Vladimír Vondráček; Michal Andrlik; Matěj Navrátíl; Radek Zapletal; Alexandra Haas; Kateřina Dědečková; Barbora Ondrová; Alexander Grebenyuk; Jozef Rosina
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

4.  Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus.

Authors:  Jahan J Mohiuddin; Krishan R Jethwa; Nikhil Grandhi; William G Breen; Xingmei Wang; Akbar Anvari; Hui Lin; Harigopal Sandhyavenu; Abigail Doucette; John P Plastaras; William G Rule; James M Metz; Kenneth W Merrell; Terence T Sio; Jonathan B Ashman; Michael G Haddock; Edgar Ben-Josef; Christopher L Hallemeier; Andrzej P Wojcieszynski
Journal:  Adv Radiat Oncol       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.